AML

Jan-Niklas Eckardt1,2, Waldemar Hahn3,4, Rhonda E Ries5,6

  • 1Department of Internal Medicine I University Hospital Carl Gustav Carus, TUD Dresden University of Technology Dresden Germany.

HemaSphere
|May 8, 2025
PubMed
概括

患者年龄显著影响急性髓性白血病 (AML) 风险,改变遗传突变如何影响结果. 考虑到特定年龄的遗传特征的量身定制的AML治疗策略对于改善患者存活率至关重要.

相关概念视频